The ongoing advancements in biomanufacturing technologies, which enhance production efficiency and reduce costs by enabling more scalable and economically viable production of complex biopharmaceuticals and biologics, are strengthening the market growth. In line with this, increasing government initiatives and incentives to promote biosimilar adoption, including streamlined regulatory pathways and reimbursement policies, are contributing to the expansion of this market. Besides this, increasing investment in research and development (R&D) of innovative biosimilar formulations, including those targeting rare diseases and new therapeutic areas, is supporting the market growth. Visit us: https://www.imarcgroup.com/biosimilar-market
Tycka om
Kommentar
Dela med sig